Jenna E van Leeuwen

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 5

Top Venues

Cancer research

Leukemia

Clinical cancer research : an official journal of the American Association for Cancer Research

Nature communications

University of Toronto (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

University of Toronto

Canada

PHD :: Medical Biophysics

University of Guelph

Canada

BSC :: Bio-Medical Science

Publications

Peter Lin, Corey Lourenco, Jennifer Cruickshank, Luis Palomero, Jenna E van Leeuwen, Amy H Y Tong, Katherine Chan, Samah El Ghamrasni, Miguel Angel Pujana, David W Cescon, Jason Moffat, Linda Z Penn
Topoisomerase 1 Inhibition in MYC-Driven Cancer Promotes Aberrant R-Loop Accumulation to Induce Synthetic Lethality. Cancer research (2023)
Jenna E van Leeuwen, Wail Ba-Alawi, Emily Branchard, Jennifer Cruickshank, Wiebke Schormann, Joseph Longo, Jennifer Silvester, Peter L Gross, David William Andrews, David W Cescon, Benjamin Haibe-Kains, Linda Z Penn, Deena M A Gendoo
Computational pharmacogenomic screen identifies drugs that potentiate the anti-breast cancer activity of statins. Nature communications 13 (1) (2022)
Rosemary Yu, Joseph Longo, Jenna E van Leeuwen, Cunjie Zhang, Emily Branchard, Mohamad Elbaz, David W Cescon, Richard R Drake, James W Dennis, Linda Z Penn
Mevalonate Pathway Inhibition Slows Breast Cancer Metastasis via Reduced N-glycosylation Abundance and Branching. Cancer research 81 (10) (2021)
Joseph Longo, Jenna E van Leeuwen, Mohamad Elbaz, Emily Branchard, Linda Z Penn
Statins as Anticancer Agents in the Era of Precision Medicine. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (22) (2020)
Joseph Longo, Petr Smirnov, Zhihua Li, Emily Branchard, Jenna E van Leeuwen, Jonathan D Licht, Benjamin Haibe-Kains, David William Andrews, Jonathan J Keats, Trevor J Pugh, Suzanne Trudel, Linda Z Penn
The mevalonate pathway is an actionable vulnerability of t(4;14)-positive multiple myeloma. Leukemia 35 (3) (2020)

Jenna E van Leeuwen.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jenna E van Leeuwen